Ä¡¸ÅÀÇ ÀÓ»óÀû Á¢±Ù (Á¦3ÆÇ)
- ÀúÀÚ(±Û)´ëÇÑÄ¡¸ÅÇÐȸ
- ÃâÆÇ»ç´ëÇÑÀÇÇмÀû
- ¹ßÇàÀÏ2021³â 01¿ù 10ÀÏ
Ä¡¸Å ȯÀÚÀÇ ±ä ¿©Á¤À» ÇÔ²²ÇÏ´Â ÀÇ»ç
±¹³» Ä¡¸Å Ä¡·á¿Í ÀÎÁöÁßÀç ¿¬±¸¸¦ À̲ô´Â ½Å°æ°ú Àü¹®ÀÇ´Ù. ¹Ì±¹ ¹öÁö´Ï¾ÆÁÖ¸³´ë ½Å°æ°ú ¿¬±¸±³¼ö·Î Ȱµ¿Çϸç Ä¡¸Å ¿¬±¸ÀÇ Çй®Àû ±â¹ÝÀ» ´ÙÁ³´Ù. ƯÈ÷ ÁßÁõ Ä¡¸Å ȯÀÚÀÇ Æò°¡¿Í Áúº´ ´Ü°è ¿¬±¸¿¡ ÁýÁßÇØ ÁßÁõ Ä¡¸Å ÀÎÁöÆò°¡ µµ±¸ÀÇ ±¹³» Àû¿ë ¿¬±¸¸¦ ¼öÇàÇϰí À̸¦ ÃâÆÇ ¹× °Ç°º¸Çè ±Þ¿© °Ë»ç·Î Á¤Âø½Ã۸ç ÁßÁõ Ä¡¸Å ¿¬±¸ÀÇ Åä´ë¸¦ ¸¶·ÃÇß´Ù. ¶ÇÇÑ ±¹³» ÃÖÃÊ·Î µµ³×ÆäÁú Àå±â Åõ¾à ¿¬±¸¸¦ ÅëÇØ Ä¡¸Å ¾à¹° Ä¡·áÀÇ ÀÓ»ó ±Ù°Å¸¦ Á¦½ÃÇßÀ¸¸ç, ¾à¹° Ä¡·á¿¡¸¸ ÀÇÁ¸ÇÏÁö ¾Ê´Â ÀÎÁöÁßÀç Ä¡·á¿Í Ä¡¸Å ¿¹¹æ ¿¬±¸¿¡µµ Èû½á ¿Ô´Ù. ´ëÇѽŰæ°úÇÐȸ ±³°ú¼ ¡º½Å°æÇС» ÃÖ½ÅÆÇ¿¡¼ ÀÎÁöÀçȰ ÆÄÆ®ÀåÀ» ¸Ã¾Æ °ü·Ã ÁýÇÊÀ» ÃѰýÇß´Ù. ÇöÀç ±¹³» ÃÖ°í ¼öÁØÀÇ ¿ä¾ç¡¤ÀçȰº´¿ø ±×·ìÀÎ º¸¹Ù½ºÀÇ·á¿ø ÀÇ·á¿øÀåÀ¸·Î¼ Ä¡¸Å ȯÀÚ¿Í °¡Á·ÀÌ Áúº´ÀÇ ±ä ¿©Á¤ ¼Ó¿¡¼µµ Á¸¾öÇÑ »îÀ» Áöų ¼ö ÀÖµµ·Ï ¿¬±¸¿Í Áø·á¿¡ Èû¾²°í ÀÖ´Ù.
| Á¦ ¸ñ | µÎ³ú¿ª·®°È | ||
|---|---|---|---|
| ÃâÆÇ»ç | ¾ÆÄ§»ç°ú | ¹ßÇàÀÏ | 2024³â 04¿ù 15ÀÏ |
| Á¦ ¸ñ | ½Å°æÇÐ(½Å°æ°ú±³°ú¼) | ||
|---|---|---|---|
| ÃâÆÇ»ç | ±ºÀÚÃâÆÇ»ç | ¹ßÇàÀÏ | 2024³â 01¿ù 01ÀÏ |
| Á¦ ¸ñ | Ä¡¸ÅÀÇ ½Å°æÇൿÁõ»ó | ||
|---|---|---|---|
| ÃâÆÇ»ç | ´ëÇÑÀÇÇмÀû | ¹ßÇàÀÏ | 2023³â 04¿ù 15ÀÏ |
| Á¦ ¸ñ | CogMCI Àç°¡Çü ÀÎÁöÁßÀçÄ¡·áÇÁ·Î±×·¥ | ||
|---|---|---|---|
| ÃâÆÇ»ç | ÀνÎÀÌÆ® | ¹ßÇàÀÏ | 2022³â 06¿ù 21ÀÏ |
| Á¦ ¸ñ | ½´ÆÛºê·¹ÀÎ ÀÎÁöÁßÀçÄ¡·áÇÁ·Î±×·¥ | ||
|---|---|---|---|
| ÃâÆÇ»ç | ÀνÎÀÌÆ® | ¹ßÇàÀÏ | 2020³â 04¿ù 10ÀÏ |
| Á¦ ¸ñ | ½Å°æ½É¸®ÀçȰ°ú Ä¡¸ÅȯÀÚ | ||
|---|---|---|---|
| ÃâÆÇ»ç | ÇÐÁö»ç | ¹ßÇàÀÏ | 2019³â 01¿ù 31ÀÏ |
| Á¦ ¸ñ | Effects of Multicomponent Exercise on Cognitive Function in Elderly Korean Individuals. | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | J Clin Neurol. |
| Á¦ ¸ñ | Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial. | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | J Clin Neurol. |
| Á¦ ¸ñ | Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer¡¯s Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study. | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2018 | ¹ßÇ¥Áö | J Alzheimers Dis. |
| Á¦ ¸ñ | Genitourinary problems in the elderly in geriatric hospitals. | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2017 | ¹ßÇ¥Áö | J Korean Med Assoc |
| Á¦ ¸ñ | "Group and home-based cognitive intervention for patients with MCI: a randomized controlled trial." | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2016 | ¹ßÇ¥Áö | Psychother Psychosom. |
| Á¦ ¸ñ | "Factors Influencing Skin Tolerability to the Rivastigmine Patch in Patients with Alzheimer¡¯s Disease." | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2015 | ¹ßÇ¥Áö | Dement Neurocogn Disord |
| Á¦ ¸ñ | "Donepezil treatment in Alzheimer¡¯s disease patients with and without cerebrovascular lesions: A preliminary report. " | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2010 | ¹ßÇ¥Áö | Geriatr Gerontol int |
Á¦°¡ °¡Àå °ü½ÉÀ» µÎ°í ¿¬±¸ÇØ ¿Â ºÐ¾ß´Â ÁßÁõ Ä¡¸Å ȯÀÚÀÇ Æò°¡¿Í Áúº´ ´Ü°è ¿¬±¸, ±×¸®°í ÀÎÁöÁßÀç Ä¡·áÀÔ´Ï´Ù. Severe Impairment Battery(SIB)ÀÇ ±¹³» Àû¿ë ¿¬±¸¸¦ ÅëÇØ °Ë»ç µµ±¸¸¦ ÃâÆÇÇÏ°í °Ç°º¸Çè ±Þ¿© °Ë»ç·Î Á¤Âø½ÃŰ´Â µ¥ ±â¿©Çß½À´Ï´Ù. ¶ÇÇÑ ÁßÁõ Ä¡¸Å Æò°¡¿Í ¾à¹° Ä¡·á, ÀÎÁöÁßÀç ¿¬±¸¸¦ ÅëÇØ Ä¡¸Å ȯÀÚÀÇ ±â´É À¯Áö¿Í »îÀÇ Áú Çâ»ó¿¡ µµ¿òÀ» ÁÖ°íÀÚ ³ë·ÂÇØ ¿Ô½À´Ï´Ù.
Àú´Â ȯÀÚ Áø·á¿¡¼ Á¤È®ÇÑ Áø´Ü°ú ÀûÁ¤ Áø·á¸¦ °¡Àå Áß¿äÇÑ °¡Ä¡·Î »ý°¢ÇÕ´Ï´Ù. ȯÀÚÀÇ Á¸¾ö¼ºÀ» Áö۰í Áúȯ¿¡ ´ëÇÑ Á¤È®ÇÑ Á¤º¸¸¦ ÃæºÐÈ÷ Àü´ÞÇÏ¿©, ȯÀÚ¿Í °¡Á·ÀÌ »óȲÀ» ÀÌÇØÇÑ °¡¿îµ¥ ½º½º·Î ³³µæÇÒ ¼ö ÀÖ´Â ¼±ÅÃÀ» ÇÒ ¼ö ÀÖµµ·Ï µ½´Â °ÍÀÌ ÀÇ»çÀÇ ¿ªÇÒÀ̶ó°í ¹Ï½À´Ï´Ù.
Àú´Â ȯÀÚÀÇ »îÀ» ¿À·¡ ÇÔ²²ÇÏ´Â ÀÇ»çÀÔ´Ï´Ù. Áúº´ÀÌ ½ÃÀÛµÈ ÀÌÈÄ ¼ö³â¿¡¼ ±æ°Ô´Â 20~30³â¿¡ À̸£´Â ½Ã°£ µ¿¾È ȯÀÚ¿Í °¡Á·ÀÇ °ç¿¡¼ ÇÔ²² ±æÀ» °É¾î°©´Ï´Ù. ¸ðµç º´À» ¿ÏÀüÈ÷ °íÄ¥ ¼ö´Â ¾øÁö¸¸, ȯÀÚ¿Í °¡Á·ÀÌ ¾î·Á¿î ¼ø°£¸¶´Ù °¡Àå ÁÁÀº ¼±ÅÃÀ» ÇÒ ¼ö ÀÖµµ·Ï µ½´Â µ¿¹ÝÀÚ°¡ µÇ°í ½Í½À´Ï´Ù. Áúº´ÀÇ ±æÀÌ Èûµé´õ¶óµµ ±× ±æÀ» È¥ÀÚ °ÈÁö ¾Êµµ·Ï ³¡±îÁö ÇÔ²²ÇϰڽÀ´Ï´Ù.

º¸¹Ù½º±â³äº´¿øÀº ·Ôµ¥ÀÇ·áÀç´ÜÀÌ ¿î¿µÇϸç, ¼¼°èÀûÀÎ º¸¹Ù½º Ä¡·á¹ýÀ» ¹ÙÅÁÀ¸·Î ±¹³» ÀçȰ ¹× ½Ç¹ö ÀÇ·á ü°è¸¦ ¼±µµÇÑ´Ù. ¼÷·ÃµÈ Àü¹® ÀÇ·áÁø°ú °íµµÈµÈ ÀçȰ ½Ã½ºÅÛÀ» ÅëÇØ ³ú½Å°æ°è ¼Õ»ó ȯÀÚÀÇ È¸º¹°ú °í·É »çȸÀÇ ¸ÂÃãÇü ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇÑ´Ù. ´Ü¼øÇÑ Ä¡·á¸¦ ³Ñ¾î Á¤¹ÐÇÑ Áø´Ü°ú °úÇÐÀû ±Ù°Å¿¡ ±â¹ÝÇÑ ÀÓ»ó ¿ª·®À¸·Î °í°´ÀÇ Àü »ý¾ÖÁֱ⠰ǰ °ü¸®¸¦ Ã¥ÀÓÁø´Ù.
°æ±âµµ °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ´ë¿ÕÆÇ±³·Î 155-7